Syndax Pharmaceuticals Inc Business Finance Contracts & Agreements
54 Contracts & Agreements
- Exchange Agreements (1 contract)
- Investor Rights Agreements (2)
- Loan Agreements (8)
- Note Agreements (2)
- Purchase Agreements (4)
- Stock Agreements (21)
- Underwriting Agreements (7)
- Warrant Agreements (9)
- Description of Capital Stock (Filed With SEC on February 27, 2024)
- Underwriting Agreement, dated December 14, 2023, by and between the Company and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Cowen and Company, LLC (Filed With SEC on December 15, 2023)
- Underwriting Agreement, dated December 6, 2022, by and between the Company and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Cowen and Company, LLC (Filed With SEC on December 7, 2022)
- First Amendment to the Companys Loan and Security Agreement with the several banks and financial institutions or entities from time-to-time party thereto and Hercules Capital,... (Filed With SEC on March 1, 2022)
- Form of Pre-Funded Warrant (2021) (Filed With SEC on December 17, 2021)
- Underwriting Agreement, dated December 15, 2021, by and among the Company and Goldman Sachs & Co. LLC (Filed With SEC on December 17, 2021)
- Stock Purchase Agreement by and between the Company and Incyte Corporation, dated as of September 24, 2021 (Filed With SEC on November 15, 2021)
- Underwriting Agreement, dated December 8, 2020, by and among the Company, Goldman Sachs & Co. LLC, Citigroup Global Markets Inc. and Cowen and Company, LLC (Filed With SEC on December 9, 2020)
- Loan and Security Agreement dated February 7, 2020 between Syndax Pharmaceuticals, Inc. and Hercules Capital, Inc (Filed With SEC on May 7, 2020)
- Underwriting Agreement, dated April 30, 2020, by and among the Company, Citigroup Global Markets Inc. and Cowen and Company, LLC (Filed With SEC on May 4, 2020)
- Description of Capital Stock (Filed With SEC on March 5, 2020)
- Purchase Agreement between the Company and the Purchasers, dated January 30, 2020 (Filed With SEC on February 4, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on February 4, 2020)
- Purchase Agreement between the Company and the Purchaser, dated March 28, 2019 (Filed With SEC on March 29, 2019)
- Purchase Agreement between the Company and the Purchasers, dated March 26, 2019 (Filed With SEC on March 29, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on March 29, 2019)
- Form of Series Warrant (Filed With SEC on March 29, 2019)
- Exchange Agreement between Syndax Pharmaceuticals, Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P. and Biotechnology Value Trading Fund OS, L.P., dated... (Filed With SEC on June 20, 2018)
- Form of Warrant Agreement (Filed With SEC on June 20, 2018)
- Purchase Agreement, dated October 17, 2017 (Filed With SEC on October 20, 2017)
- 3,750,000 Shares SYNDAX PHARMACEUTICALS, INC. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT (Filed With SEC on May 25, 2017)
- SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on January 4, 2016)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on January 4, 2016)
- SOLAR CAPITAL LOAN ANDSECURITY AGREEMENT (Filed With SEC on January 4, 2016)
- SYNDAX PHARMACEUTICALS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on January 4, 2016)
- SYNDAX PHARMACEUTICALS, INC. 2007 STOCK PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on January 4, 2016)
- SYNDAX PHARMACEUTICALS, INC. 2007 STOCK PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on January 4, 2016)
- AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN (Filed With SEC on January 4, 2016)
- AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN (Filed With SEC on January 4, 2016)
- AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN (Filed With SEC on January 4, 2016)
- AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN (Filed With SEC on January 4, 2016)
- AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN (Filed With SEC on January 4, 2016)
- AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN (Filed With SEC on January 4, 2016)
- SYNDAX PHARMACEUTICALS, INC. 2007 STOCK PLAN (Filed With SEC on January 4, 2016)
- WARRANT AGREEMENT between SYNDAXPHARMACEUTICALS, INC. and BAYER SCHERING PHARMA AG Dated as of March 26, 2007 Table of Contents (Filed With SEC on January 4, 2016)
- SYNDAX PHARMACEUTICALS, INC. THIRD AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS (Filed With SEC on January 4, 2016)
- SYNDAX PHARMACEUTICALS, INC. WARRANT CERTIFICATE (Filed With SEC on January 4, 2016)
- Shares Syndax Pharmaceuticals, Inc. Common Stock ($0.0001 Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on January 4, 2016)
- SYNDAX PHARMACEUTICALS, INC. CONVERTIBLE NOTE PURCHASE AGREEMENT (Filed With SEC on November 21, 2014)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 21, 2014)
